We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$647M
AUM Growth
+$10.5M
Cap. Flow
-$8.51M
Cap. Flow %
-1.31%
Top 10 Hldgs %
28.67%
Holding
171
New
6
Increased
31
Reduced
95
Closed
4

Top Buys

Rank Stock Value
1
GLW icon
Corning
GLW
+$3.74M
2
JWN
Nordstrom
JWN
+$3.66M
3
VOD icon
Vodafone
VOD
+$967K
4
SYK icon
Stryker
SYK
+$884K
5
EMR icon
Emerson Electric
EMR
+$822K

Top Sells

Rank Stock Value
1
WLK icon
Westlake Corp
WLK
+$5.61M
2
DD icon
DuPont de Nemours
DD
+$3.44M
3
WOLF icon
Wolfspeed
WOLF
+$2.96M
4
VZ icon
Verizon
VZ
+$2.45M
5
AMGN icon
Amgen
AMGN
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Healthcare 17.39%
3 Energy 12.25%
4 Industrials 11.91%
5 Consumer Staples 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
126
Texas Instruments
TXN
$247B
$402K 0.06%
7,526
-600
-7% -$30.4K
HD icon
127
Home Depot
HD
$340B
$372K 0.06%
3,540
-568
-14% -$55.2K
GPC icon
128
Genuine Parts
GPC
$17.8B
$358K 0.06%
3,362
– –
INCY icon
129
Incyte
INCY
$25.2B
$358K 0.06%
4,895
– –
POPE
130
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$350K 0.05%
5,500
– –
NVO
131
Novo Nordisk
NVO
$227B
$349K 0.05%
16,482
-80
-0.5% -$1.79K
FISV
132
Fiserv Inc
FISV
$29.7B
$338K 0.05%
9,520
-2,400
-20% -$82.2K
ESRX
133
DELISTED
Express Scripts Holding Company
ESRX
$334K 0.05%
3,940
-89
-2% -$6.95K
VRTX icon
134
Vertex Pharmaceuticals
VRTX
$125B
$333K 0.05%
2,807
– –
STJ
135
DELISTED
St Jude Medical
STJ
$322K 0.05%
4,950
– –
ISRG icon
136
Intuitive Surgical
ISRG
$127B
$307K 0.05%
5,229
-117
-2% -$6.52K
EOG icon
137
EOG Resources
EOG
$77.6B
$305K 0.05%
3,315
-125
-4% -$11.6K
HUB.B
138
DELISTED
HUBBELL INC CL-B
HUB.B
$305K 0.05%
2,855
– –
ORCL icon
139
Oracle
ORCL
$336B
$304K 0.05%
6,768
-66
-1% -$2.69K
REGN icon
140
Regeneron Pharmaceuticals
REGN
$72.9B
$304K 0.05%
742
– –
SIAL
141
DELISTED
SIGMA - ALDRICH CORP
SIAL
$302K 0.05%
2,200
– –
STR
142
DELISTED
QUESTAR CORP
STR
$297K 0.05%
11,732
– –
SYT
143
DELISTED
Syngenta Ag
SYT
$275K 0.04%
4,281
– –
CPB icon
144
Campbell Soup
CPB
$6.86B
$269K 0.04%
6,117
– –
CELG
145
DELISTED
Celgene Corp
CELG
$265K 0.04%
2,372
– –
MWV
146
DELISTED
MEADWESTVACO CORP
MWV
$262K 0.04%
5,903
-132
-2% -$5.71K
AME icon
147
Ametek
AME
$53.8B
$255K 0.04%
4,847
-230
-5% -$11.7K
MDVN
148
DELISTED
MEDIVATION, INC.
MDVN
$250K 0.04%
5,014
– –
OMC icon
149
Omnicom Group
OMC
$23.6B
$247K 0.04%
3,191
– –
BMRN icon
150
BioMarin Pharmaceuticals
BMRN
$12B
$245K 0.04%
+2,708
New +$225K
3 4 5
6
7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q4 2014 Portfolio in Review

As of Q4 2014, Grandfield & Dodd held 171 positions worth $647M, up 1.7% from $636M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grandfield & Dodd's Q4 2014 filing shows 6 new, 31 increased, 95 reduced and 4 closed positions. Its largest new stake was Enterprise Products Partners: 15,108 shares worth $546K. The largest sale was Westlake Corp, an estimated $5.61M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Energy.

  • Grandfield & Dodd's largest Q4 2014 buy was Enterprise Products Partners: 15,108 shares worth $546K.
  • Grandfield & Dodd added most to Corning in Q4 2014, an estimated $3.74M increase.
  • Grandfield & Dodd's biggest Q4 2014 reduction was Westlake Corp, cutting an estimated $5.61M.
  • Grandfield & Dodd fully exited Phillips 66 in Q4 2014, selling an estimated $309K.
  • Grandfield & Dodd's ten largest holdings make up 29% of its $647M portfolio in Q4 2014.
  • Grandfield & Dodd opened 6 new positions and closed 4 in Q4 2014.
  • Grandfield & Dodd's portfolio value rose 1.7% quarter-over-quarter to $647M.

Based on Grandfield & Dodd's 13F filing for Q4 2014, filed 5 Feb 2015.